Intercure Ltd

InterCure Ltd. engages in the business of medical cannabis and biomedicine. It operates through the Investments in Biomed Portfolio Companies and Investments in Medical Cannabis Companies segments. The company was founded by Benjamin Gavish and Erez Gavish on November 20, 1994 and is headquartered in Herzliya, Israel.

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q2 2024

InterCure reports record 2022 revenues, poised for global expansion

InterCure had a successful year in 2022, achieving record revenues and positioning itself for global expansion. The company's focus on the Israeli market, expansion of cultivation facilities, and addition of new product strains have been key drivers of growth. Despite challenges in patient procurement and regulatory complexities, InterCure is well-prepared to leverage opportunities in international markets.

InterCure reports record revenue and positive cash flow for 2022

InterCure's Q4 2022 earnings call highlighted a successful 2022, with record revenue and positive cash flow. The company's focus on leading the Israeli market, scaling up operations, and navigating market dynamics and regulatory differences positions it for continued growth. Despite industry challenges, InterCure is well-prepared to capitalize on opportunities presented by pricing trends and prescription reforms.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

InterCure Ltd. engages in the provision of business of medical cannabis and biomedicine. It operates through the Investments in Biomed Portfolio Companies in the Biomed Sector and Investments in the Medical Cannabis Sector segments. The company was founded by Benjamin Gavish and Erez Gavish on November 20, 1994 and is headquartered in Herzliya, Israel.

Estimated r evenue reach es CAD$3 6 million 1 ( a record NIS 95 million )

InterCure Reports Record Preliminary 2022 Second Quarter Revenue – More Than Double YoY and 9% QoQ Growth

NEW YORK and TORONTO and HERZLIYA, Israel, June 21, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) ("InterCure" or the “Company”) announced today the successful opening of the first flagship Cookies store in Austria, located in the Neubau district of Vienna.

InterCure and Cookies Launch Flagship Retail Location in Vienna, Austria

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

AdvisorShares Pure US Cannabis ETF

Trulieve Cannabis Corp.

Ted Waller returns to discuss staying bullish but getting more realistic about the cannabis industry. Limited growth rates, margin compression and the need to keep our emotions out of investing.

Buying Into A Down Market (Podcast Transcript)

Buying Into A Down Market

Most of cannabis industry growth will occur outside North America. The road to global growth starts with medical cannabis.

InterCure Is Growing In The Massive Global Cannabis Market

Aurora Cannabis

Agrify

Flora Growth Corp

High Tide

InMed Pharmaceuticals

WM Technology

Urban-gro

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks this week, and look ahead to how the cannabis industry will continue to develop in 2022.

The Holiday-Shortened Week Didn't Stop These 8 Cannabis Stocks

Cookies Be'er Sheva is the largest medical cannabis dedicated pharmacy in Israel Cookies Be'er Sheva is the largest medical cannabis dedicated pharmacy in Israel

InterCure and Cookies Successfully Launch Flagship Pharmacy in Be'er Sheva, Israel

Subversive Metaverse ETF

Michael Auerbach, Chairman of The Parent Company, updates us on the growth that hasn't shown up the way we expected. InterCure and the Israeli market.

Still A Lot More Work To Do In The Cannabis Industry (Podcast Transcript)

Canopy Growth

Greenlane Holdings

GrowGeneration Corp

Innovative Industrial Properties

Incannex Healthcare Inc

Akerna Corp

Leafly Holdings

SNDL Inc.

What Happened With These 11 Cannabis Stocks This Week?

InterCure Ltd. (NASDAQ:INCR ) Q1 2022 Earnings Conference Call May 17, 2022 8:00 AM ET Company Participants Adam Haliva - Communications Officer Alex Rabinovitch - Chief Executive Officer Amos Cohen - Chief Financial Officer Conference Call Participants Matt Bottomley - Canaccord Operator Hello, thank you for standing-by and welcome to the InterCure First Quarter 2022 Earnings Call and Webcast.

InterCure Ltd.'s (INCR) CEO Alex Rabinovitch on Q1 2022 Results - Earnings Call Transcript

Record revenue of $3 4 1 million in the first quarter of 2022

InterCure Begins 2022 with Record Breaking First Quarter Financial Results

Conference call scheduled for Tuesday, May 17, 2022, at 8:00am ET Conference call scheduled for Tuesday, May 17, 2022, at 8:00am ET

InterCure to Release its Q1 2022 Results and Hold a Conference Call

NEW YORK, TORONTO, and HERZLIYA, Israel, May 09, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that that Alex Rabinovitch, Chief Executive Officer and Amos Cohen, Chief Financial Officer, will participate in the following investor conferences in May 2022.

InterCure to Participate in Upcoming Investor Conferences in May 2022

Michael Auerbach, Founder and Chairman of Subversive Capital and The Parent Company, updates us on GRAMF and the growth that hasn't shown up the way we expected. InterCure and the Israeli market.

Still A Lot More Work To Do In The Cannabis Industry

NEW YORK and TORONTO and HERZLIYA, Israel, May 03, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the “Company”) today announced that Alexander Rabinovitch, CEO of InterCure, will participate in Alliance Global Partners Spring Consumer Cannabis Conference, taking place May 3, 2022.

InterCure to Participate in A.G.P.'s Spring Consumer Cannabis Conference

PepsiCo

Tilray Brands

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks, and look at how the cannabis industry is shaping up as we kick off 2022.

5 Cannabis Stocks to Watch Alongside MORE Act Momentum

Another record year with continued industry leading growth and profitability supported by focused strategy and execution

InterCure Reports Record Breaking Q4 and 2021 Results – Exceeded Preliminary Results

Delay in publication of the Audited Results due to immaterial technical audit matters

InterCure Expects to Publish its full Audited Fourth Quarter and Full Year 2021 Results Prior to the TSX Closing on April 5, 2022

Fourth quarter 2021 Revenue and Adjusted EBITDA 2 of $33 million and $9 million, representing an increase of almost 200% and 140% YoY, respectively

CORRECTING and REPLACING -- InterCure Estimates Record Fourth Quarter and Fiscal Year End 2021 Results(1)

InterCure Estimates Record Fourth Quarter and Fiscal Year End 2021 Results(1)

Will release financial results for the fourth quarter of 2021 before market open on Monday, April 4, 2022

InterCure to Announce Q4 & Year-End 2021 Financial Results on April 4, 2022

Cannabis Growth ETF

Amplify Seymour Cannabis ETF

HEXO Corp

Hydrofarm Holdings Group

Amplify Alternative Harvest ETF

Amplify US Alternative Harvest ETF

Advisorshares Poseidon Dynamic Cannabis ETF

Nick Gastevich, one of our favorite commenters on Seeking Alpha, returns to the show to catch us up on the state of cannabis investing. Wave of new states legalizing cannabis now especially important in the face of long federal delays.

Searching For Cannabis Catalysts (Podcast Transcript)

Mr. Rabinovitch is one of the global cannabis senior executives to participate Mr. Rabinovitch is one of the global cannabis senior executives to participate

InterCure to Participate in ROTH Capital's 34th Annual Conference

The partnership will focus on the new CBD wellness market in Israel

InterCure Announces Partnership with Altman Health

cbdMD Inc

Clever Leaves Holdings Inc

Evogene

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks, and look at how the cannabis industry is evolving as we make our way through 2022.

These Pot Stocks Made Major International Moves This Week

News for Intercure Ltd Stock (INCR)